Kündig

Fakultäten » Medizinische Fakultät » Dermatologische Klinik » PD Dr. Thomas Kündig » Kündig

Completed research project

Title / Titel	VLP based melanoma vaccine
PDF	Abstract (PDF, 14 KB)
Summary / Zusammenfassung	A melanoma vaccine based on the virus like particle platform is used to induce CD8+ T cell responses against MelanA in two pilot clinical trials. It is also assessed whether or not direct intralymphatic delivery enhances the T cell response against the vaccine.
Project leadership and contacts / Projektleitung und Kontakte	PD Dr. Thomas Kündig (Project Leader) thomas.kuendig@usz.ch
Funding source(s) / Unterstützt durch	Private Sector (e.g. Industry)
In collaboration with / In Zusammenarbeit mit	PD Dr. Martin F. Bachmann CSO Cytos Biotechnology AG Schlieren, ZH Switzerland
Duration of Project / Projektdauer	Jun 2007 to May 2010